FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Insmed's Trailing 12-Month Free Cash Flow is $-705.8 Mil, and Market Cap is $12,467.4 Mil. Therefore, Insmed's FCF Yield % for today is -5.66%.
The historical rank and industry rank for Insmed's FCF Yield % or its related term are showing as below:
INSM'
s FCF Yield % Range Over the Past 10 Years
Min: -23.83 Med: -12.92 Max: -4.83
Current: -5.66
During the past 13 years, the highest FCF Yield % of Insmed was -4.83%. The lowest was -23.83%. And the median was -12.92%.
INSM's FCF Yield % is ranked better than 68.07% of 1500
companies
in the Biotechnology industry
Industry Median: -16.225
vs INSM: -5.66
Insmed's FCF Margin % for the quarter that ended in Dec. 2024 was -194.13%.
Insmed FCF Yield % Historical Data
The historical data trend for Insmed's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Insmed's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Insmed's FCF Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Insmed's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Insmed's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Insmed FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Insmed FCF Yield % Related Terms
Thank you for viewing the detailed overview of Insmed's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
INSM has been successfully added to your 